According to new market research, the global smart drug delivery systems market reached $12 billion in 2024 and is expected ...

SIGNIFICANT EVENTS DURING 1 JANUARY - 31 MARCH 2025Iconovo and Lonza have entered a collaboration to develop spray-dried formulations of an intranasal biologic drug for Iconovo's proprietary intranasa ...

The sarcopenia market remains largely untapped, with significant unmet medical needs and no approved drug therapies in major markets. As global demographics shift toward older populations, ...

Sanofi SNY reported first-quarter 2025 adjusted earnings of 94 cents per American depositary share, which beat the Zacks ...

A dad died in hospital just 11 days after being released from prison early to help ease issues of overcrowding. Alan Blake ...

Cancer is one of the leading causes of death globally, with nearly 20 million new cases and 9.7 million deaths in 2022.

TNF Pharmaceuticals, Inc. ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, and Renova Health ...

GLP-1s exploded seemingly out of nowhere, straining pharmacy plan bottom lines. Psoriasis treatments don't have to follow the ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.

One of the most commonly taken drugs in the UK can trigger a debilitating cough that takes up to three months to disappear, a ...